Australian biopharmaceutical company Opthea has announced positive clinical data for novel therapies developed to treat highly prevalent and progressive retinal diseases.

The Australian Medical Students’ Association (AMSA) has described as “simplistic” the Group of Eight (Go8) Universities’ recommendation for an additional 1,000 medical student Commonwealth

Optical company, Shamir has celebrated 50 years of growth in the global ophthalmic industry, recognising past triumphs, and promising ambitious future endeavors in the

A study conducted in the United States has found that patients are open to immediate sequential bilateral cataract surgery (ISBCS).